The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Brian G. Weinshenker

Mayo Clinic

Rochester

MN 55905

USA

[email]@mayo.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Mayo Clinic, Rochester, MN 55905, USA. 2003 - 2012
  • Correspondence & reprint requests to Dr. Weinshenker:. 2012
  • Department of Neurology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, USA. 2000 - 2008

References

  1. Industrial pharmaceutical drug research has done more for the health of people with MS than academic neurologists: no. Weinshenker, B.G. Mult. Scler. (2012) [Pubmed]
  2. Solitary sclerosis: Progressive myelopathy from solitary demyelinating lesion. Schmalstieg, W.F., Keegan, B.M., Weinshenker, B.G. Neurology (2012) [Pubmed]
  3. Neuromyelitis optica: clinical syndrome and the NMO-IgG autoantibody marker. Weinshenker, B.G., Wingerchuk, D.M. Curr. Top. Microbiol. Immunol. (2008) [Pubmed]
  4. Neuromyelitis optica is distinct from multiple sclerosis. Weinshenker, B.G. Arch. Neurol. (2007) [Pubmed]
  5. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Weinshenker, B.G., Wingerchuk, D.M., Vukusic, S., Linbo, L., Pittock, S.J., Lucchinetti, C.F., Lennon, V.A. Ann. Neurol. (2006) [Pubmed]
  6. NMO-IgG: a specific biomarker for neuromyelitis optica. Weinshenker, B.G., Wingerchuk, D.M., Pittock, S.J., Lucchinetti, C.F., Lennon, V.A. Dis. Markers (2006) [Pubmed]
  7. Neuromyelitis optica: what it is and what it might be. Weinshenker, B.G. Lancet (2003) [Pubmed]
  8. Plasma exchange for severe attacks of inflammatory demyelinating diseases of the central nervous system. Weinshenker, B.G. J. Clin. Apher (2001) [Pubmed]
  9. Association of a tumor necrosis factor alpha polymorphism with MS susceptibility. Weinshenker, B.G., Hebrink, D.D., Atkinson, E., Kantarci, O.H. Neurology (2001) [Pubmed]
  10. Genetic variation in the transforming growth factor beta1 gene in multiple sclerosis. Weinshenker, B.G., Hebrink, D., Kantarci, O.H., Schaefer-Klein, J., Atkinson, E., Schaid, D., McMurray, C.M. J. Neuroimmunol. (2001) [Pubmed]
  11. Genetic variation in the B7-1 gene in patients with multiple sclerosis. Weinshenker, B.G., Hebrink, D.D., Klein, C., Atkinson, E.J., O'Brien, P.C., McMurray, C.T. J. Neuroimmunol. (2000) [Pubmed]
 
WikiGenes - Universities